Skip to main content
. 2020 Sep 30;12(10):2827. doi: 10.3390/cancers12102827

Figure 2.

Figure 2

Swimmers plot detailing progression survival (PFS) and overall survival (OS) after one year of follow-up of patients receiving intercurrent steroids for cancer-related (blue) and not related (green) indications. Abbreviations: Immune-related adverse events (irAEs); progressive disease (PD).